Hajime Yamazaki

Hajime Yamazaki

Auto-generated profile, based on publicly available information

Hajime Yamazaki

Section of Clinical Epidemiology, Department of Community Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MSMasahiro Shiokawa
Masahiro Shiokawa
YKYuzo Kodama
Yuzo Kodama
KSKiyotoshi Sekiguchi
Kiyotoshi Sekiguchi
TKTakeshi Kuwada
Takeshi Kuwada
TTTeruko Tomono
Teruko Tomono
TCTsutomu Chiba
Tsutomu Chiba
The extracellular matrix protein laminin 511 is an autoantigen involved in the pathophysiology of autoimmune pancreatitis.

8 July 2015 in Diabetes Care
Verified
Journal Article
Open access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
TTToru Tsuboya
Toru Tsuboya
KTKunihiko Tsuji
Kunihiko Tsuji
MDMitsuru Dohke
Mitsuru Dohke
HMHiroyuki Maguchi
Hiroyuki Maguchi
OBJECTIVE Only a few studies have evaluated the long-term effects of nonalcoholic fatty liver disease (NAFLD) on type 2 diabetes mellitus (T2DM), and none have examined whether NAFLD improvement reduces T2DM incidence. We investigated the association between NAFLD improvement and T2DM incidence. RESEARCH DESIGN AND METHODS Between 2000 and 2012, 4,604 participants who underwent a health check twice with >10 years between were enrolled. Exclusion criteria were positive hepatitis B surface antigen, positive hepatitis C antibody, ethanol intake >20 g/day, and diabetes. The 3,074 eligible participants were divided into an NAFLD group (n = 728) and a non-NAFLD group (n = 2,346) according to ultrasonography-detected fatty liver. The NAFLD group was categorized into an improved group (n = 110) and a sustained NAFLD group (n = 618) based on fatty liver disappearance at the second visit. Incident T2DM odds ratios (ORs) were estimated by logistic regression models adjusted for age, sex, BMI, impaired fasting glucose, family history of diabetes, dyslipidemia, hypertension, and physical exercise. RESULTS T2DM occurred in 117 participants (16.1%) in the NAFLD group and 72 (3.1%) in the non-NAFLD group. NAFLD at baseline was associated with T2DM incidence (multivariate OR 2.37 [95% CI 1.60–3.52]). T2DM occurred in 7 participants (6.4%) in the improved group and in 110 (17.8%) in the sustained NAFLD group. NAFLD improvement was associated with reduced T2DM incidence (multivariate OR 0.27 [95% CI 0.12–0.61]). CONCLUSIONS NAFLD improvement is associated with T2DM incidence reduction.

15 July 2016 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
TTToru Tsuboya
Toru Tsuboya
AKAkio Katanuma
Akio Katanuma
YKYoshihisa Kodama
Yoshihisa Kodama
STShinichi Tauchi
Shinichi Tauchi
HMHiroyuki Maguchi
Hiroyuki Maguchi
OBJECTIVE: Previous cross-sectional studies have shown that attenuation in the pancreas seen on unenhanced computed tomography (CT) scans was inversely correlated with histologic pancreatic fat, and that fatty pancreas was associated with type 2 diabetes mellitus (T2DM). However, no longitudinal study has evaluated whether fatty pancreas increases the incidence of T2DM. We conducted a cohort study to investigate the association between fatty pancreas and the incidence of T2DM. RESEARCH DESIGN AND METHODS: A total of 813 participants without diabetes underwent health checks by unenhanced CT scanning in 2008 and 2009, and were observed for a median follow-up period of 5.06 (interquartile range 3.01–5.92) years. Attenuation in three regions of the pancreas seen on an unenhanced CT scan was measured, and the mean pancreatic attenuation was calculated to evaluate fatty pancreas at baseline; the more severe the fatty pancreas, the lower the mean pancreatic attenuation. The incident T2DM hazard ratios (HRs) for the association between fatty pancreas and T2DM incidence were estimated by Cox proportional hazards models adjusted for age, sex, BMI, liver attenuation seen on unenhanced CT scan, and alcohol intake of ≥20 g/day. RESULTS: T2DM occurred in 62 participants (7.6%) during the follow-up period. The higher pancreas attenuation (i.e., less pancreatic fat) at baseline was associated with decreased T2DM incidence in a univariate analysis (crude HR 0.97 [95% CI 0.96–0.99]); and fatty pancreas (lower pancreas attenuation) was positively associated with increased T2DM incidence. However, the association was substantially explained by the confounders (multivariate HR 1.00 [95% CI 0.98–1.02]). CONCLUSIONS: Fatty pancreas was not independently associated with future T2DM.

20 June 2022 in Diabetes
Verified
Journal Article
Closed access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
STShinichi Tauchi
Shinichi Tauchi
JMJürgen Machann
Jürgen Machann
THTobias Haueise
Tobias Haueise
YYYosuke Yamamoto
Yosuke Yamamoto
MHMartin Heni
Martin Heni
Fat accumulation in the liver, pancreas, skeletal muscle, and visceral bed relates to type 2 diabetes (T2D). However, the distribution of fat among these compartments is heterogenous and whether specific distribution patterns indicate high T2D risk is unclear. We therefore investigated fat distribution patterns and their link to future T2D. From 2,168 individuals without diabetes who underwent computed tomography in Japan, this case-cohort study included 658 randomly selected individuals and 146 incident cases of T2D over 6 years of follow-up. Using data-driven analysis (k-means) based on fat content in the liver, pancreas, muscle, and visceral bed, we identified four fat distribution clusters: hepatic steatosis, pancreatic steatosis, trunk myosteatosis, and steatopenia. In comparisons with the steatopenia cluster, the adjusted hazard ratios for incident T2D were 4.02 (95% CI 2.27–7.12) for the hepatic steatosis cluster, 3.38 (1.65–6.91) for the pancreatic steatosis cluster, and 1.95 (1.07–3.54) for the trunk myosteatosis cluster. The clusters were replicated in 319 German individuals without diabetes who underwent MRI and metabolic phenotyping. The distribution of the glucose area under the curve across the four clusters found in Germany was similar to the distribution of T2D risk across the four clusters in Japan. Insulin sensitivity and insulin secretion differed across the four clusters. Thus, we identified patterns of fat distribution with different T2D risks presumably due to differences in insulin sensitivity and insulin secretion.

19 October 2016 in Endoscopy
Verified
Journal Article
Closed access
PDF file
KYKei Yane
Kei Yane
AKAkio Katanuma
Akio Katanuma
HMHiroyuki Maguchi
Hiroyuki Maguchi
KTKuniyuki Takahashi
Kuniyuki Takahashi
TKToshifumi Kin
Toshifumi Kin
MNMasanori Nojima
Masanori Nojima
Background and study aims: Short-type single-balloon enteroscope (short SBE)-assisted endoscopic retrograde cholangiopancreatography (ERCP) is a promising alternative treatment in postsurgical altered anatomy. However, it is technically demanding, and factors affecting its technical difficulty have not yet been clarified. This study aimed to examine the procedural success rate of short SBE-assisted ERCP and the potential factors affecting procedural failure. Patients and methods: A total of 117 consecutive patients (203 procedures) with surgically altered anatomy underwent ERCP using prototype short SBEs. The procedural success rate of short SBE-assisted ERCP and the potential factors affecting procedural failure were examined retrospectively. Results: The enteroscopy success rate and procedural success rate were 92.6 % (95 % confidence interval [CI] 88.1 % – 95.8 %) and 81.8 % (95 %CI 75.8 % – 86.8 %), respectively. Multivariate analyses indicated that pancreatic indication (odds ratio [OR] 4.35, 95 %CI 1.67 – 11.4), first ERCP attempt (OR 6.03, 95 %CI 2.17 – 16.8), and no transparent hood (OR 4.61, 95 %CI 1.48 – 14.3) were potential risk factors for procedural failure. Conclusions: Short SBE-assisted ERCP was effective in postsurgical altered anatomy. This large case series suggested the potential factors affecting procedural failure.

3 April 2020 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
HYHajime Yamazaki
Hajime Yamazaki
STShinichi Tauchi
Shinichi Tauchi
JWJui Wang
Jui Wang
MDMitsuru Dohke
Mitsuru Dohke
NHNagisa Hanawa
Nagisa Hanawa
YYYosuke Yamamoto
Yosuke Yamamoto